Renflexis, a Remicade Biosimilar, Is Now Available in the US

Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab), is now available in the United States for the treatment of ankylosing spondylitis and other conditions. The launch was recently announced by Samsung Bioepis as the company’s first biosimilar approved in the U.S. Renflexis was approved by the U.S. Food and Drug Administration (FDA) in…

Statins’ Dual Effect May Extend Survival of Ankylosing Spondylitis Patients, Study Finds

Cholesterol-lowering medications called statins may lower mortality rates in patients with ankylosing spondylitis more efficiently than in the general population, new research suggests. The study, “Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study,” was published in the journal Annals of the Rheumatic Diseases (ARD).

European Commission Approves Sandoz Biosimilar Erelzi to Treat Various Inflammatory Diseases

The European Commission recently approved Erelzi, a biosimilar etanercept drug manufactured by the Sandoz division of Switzerland’s Novartis, for all therapeutic indications of its reference medicine Enbrel (etanercept), including ankylosing spondylitis. The June 27 announcement followed an extensive analytical, preclinical and clinical program focused on Erelzi, formerly known…